Sellas Life Sciences Stock Fundamentals
| SLS Stock | USD 1.20 0.03 2.56% |
Sellas Life Sciences fundamentals help investors to digest information that contributes to Sellas Life's financial success or failures. It also enables traders to predict the movement of Sellas Stock. The fundamental analysis module provides a way to measure Sellas Life's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Sellas Life stock.
At this time, Sellas Life's Interest Expense is comparatively stable compared to the past year. EBITDA is likely to gain to about 555.5 K in 2024, whereas Operating Income is likely to drop (39.8 M) in 2024. Sellas | Select Account or Indicator |
Sellas Life Sciences Company Return On Equity Analysis
Sellas Life's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Sellas Life Return On Equity | -8.88 |
Most of Sellas Life's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Sellas Life Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Sellas Total Stockholder Equity
Total Stockholder Equity |
|
Based on the latest financial disclosure, Sellas Life Sciences has a Return On Equity of -8.8806. This is 62.95% lower than that of the Biotechnology sector and 75.64% lower than that of the Health Care industry. The return on equity for all United States stocks is notably higher than that of the company.
Sellas Life Sciences Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Sellas Life's current stock value. Our valuation model uses many indicators to compare Sellas Life value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Sellas Life competition to find correlations between indicators driving Sellas Life's intrinsic value. More Info.Sellas Life Sciences is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . At this time, Sellas Life's Return On Equity is comparatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Sellas Life by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Sellas Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Sellas Life's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Sellas Life could also be used in its relative valuation, which is a method of valuing Sellas Life by comparing valuation metrics of similar companies.Sellas Life is currently under evaluation in return on equity category among its peers.
Sellas Fundamentals
| Return On Equity | -8.88 | ||||
| Return On Asset | -1.29 | ||||
| Current Valuation | 64 M | ||||
| Shares Outstanding | 70.38 M | ||||
| Shares Owned By Insiders | 0.24 % | ||||
| Shares Owned By Institutions | 7.36 % | ||||
| Number Of Shares Shorted | 8.77 M | ||||
| Price To Book | 5.31 X | ||||
| Price To Sales | 26.90 X | ||||
| Gross Profit | 900 K | ||||
| EBITDA | 529 K | ||||
| Net Income | (37.34 M) | ||||
| Cash And Equivalents | 26.99 M | ||||
| Cash Per Share | 1.31 X | ||||
| Total Debt | 906 K | ||||
| Debt To Equity | 0.06 % | ||||
| Current Ratio | 2.36 X | ||||
| Book Value Per Share | (0.25) X | ||||
| Cash Flow From Operations | (31.41 M) | ||||
| Short Ratio | 14.07 X | ||||
| Earnings Per Share | (0.67) X | ||||
| Target Price | 5.83 | ||||
| Number Of Employees | 16 | ||||
| Beta | 2.4 | ||||
| Market Capitalization | 82.35 M | ||||
| Total Asset | 6.22 M | ||||
| Retained Earnings | (217.24 M) | ||||
| Working Capital | (10.56 M) | ||||
| Net Asset | 6.22 M |
About Sellas Life Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Sellas Life Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sellas Life using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sellas Life Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 2.9 M | 2.7 M | |
| Stock Based Compensation To Revenue | 1.55 | 1.63 | |
| Sales General And Administrative To Revenue | 11.32 | 11.89 | |
| Research And Ddevelopement To Revenue | 27.24 | 28.60 | |
| Capex To Revenue | 5.18 | 4.20 | |
| Revenue Per Share | 0.06 | 0.06 | |
| Ebit Per Revenue | (48.24) | (45.83) |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Sellas Stock Analysis
When running Sellas Life's price analysis, check to measure Sellas Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sellas Life is operating at the current time. Most of Sellas Life's value examination focuses on studying past and present price action to predict the probability of Sellas Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sellas Life's price. Additionally, you may evaluate how the addition of Sellas Life to your portfolios can decrease your overall portfolio volatility.